<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04804735</url>
  </required_header>
  <id_info>
    <org_study_id>IC 2020-03</org_study_id>
    <nct_id>NCT04804735</nct_id>
  </id_info>
  <brief_title>Use of Virtual Reality Mask or Music Therapy for Analgesia and Anxiolytic Purpose When Totally IVAD for Chemotherapy Under Local Anesthesia</brief_title>
  <acronym>REVCCI</acronym>
  <official_title>Use of Virtual Reality Mask or Music Therapy for Analgesia and Anxiolytic Purpose When Totally Implanted Venous Access Device (IVAD) for Chemotherapy Under Local Anesthesia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Institut Curie</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Institut Curie</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Evaluate 2 medical devices on pain average and/or anxiety average in the totally Implanted&#xD;
      Venous Access Device (IVAD) procedure under local anesthesia.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Evaluate the efficacy of virtual reality and music therapy on pain average and/or anxiety&#xD;
      average in the totally Implanted Venous Access Device (IVAD) procedure under local&#xD;
      anesthesia.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">October 1, 2021</start_date>
  <completion_date type="Anticipated">September 2, 2022</completion_date>
  <primary_completion_date type="Anticipated">July 1, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>mean of pain felt during the whole IVAD procedure</measure>
    <time_frame>1 day</time_frame>
    <description>pain means will be measured with the Numerical Rating Scale (NRS) from 0 to 10 with 0 corresponding to no pain and 10 the maximum pain feeling.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>mean of anxiety felt during the whole IVAD procedure</measure>
    <time_frame>1 day</time_frame>
    <description>Anxiety means will be measured with the Numerical Rating Scale (NRS) from 0 to 10 with 0 corresponding to no anxiety and 10 the maximum anxiety feeling.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Correlation coefficient between the ANI air under the curve and the pain measure with the numerical rating scale.</measure>
    <time_frame>1 day</time_frame>
    <description>Correlation coefficient between the ANI air under the curve and the pain measure with the numerical rating scale.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Tolerance evaluated by NRS and responses to the closed questions (dizziness, nausea, suffocating feeling) completed at the end of the procedure.</measure>
    <time_frame>1 day</time_frame>
    <description>NRS and responses to the closed questions</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Global patient satisfaction of NRS and comparison between the 3 groups.</measure>
    <time_frame>1 day</time_frame>
    <description>patient satisfaction of NRS</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain NRS means felt during the procedure and comparison.</measure>
    <time_frame>1 day</time_frame>
    <description>NRS means</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Anxiety NRS means felt during the procedure and comparison.</measure>
    <time_frame>1 day</time_frame>
    <description>NRS means</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">127</enrollment>
  <condition>Implanted Venous Access Device</condition>
  <arm_group>
    <arm_group_label>REV : local anesthesia and virtual reality</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Use of virtual reality device in Implanted Venous Access Device (IVAD) procedure under local anesthesia</description>
  </arm_group>
  <arm_group>
    <arm_group_label>MUS : local anesthesia and music therapy</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Use of musicotherapy tool in Implanted Venous Access Device (IVAD) procedure under local anesthesia</description>
  </arm_group>
  <arm_group>
    <arm_group_label>CONTROL : standard local anesthesia</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Implanted Venous Access Device (IVAD) procedure under local anesthesia as standard of care</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>REV : local anesthesia and virtual reality</intervention_name>
    <description>REV : local anesthesia and virtual reality in Implanted Venous Access Device (IVAD) procedure under local anesthesia</description>
    <arm_group_label>REV : local anesthesia and virtual reality</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>MUS : local anesthesia and music therapy</intervention_name>
    <description>MUS : local anesthesia and music therapy in Implanted Venous Access Device (IVAD) procedure under local anesthesia</description>
    <arm_group_label>MUS : local anesthesia and music therapy</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Patient aged between 18 and 85 years.&#xD;
&#xD;
          2. Patient with cancer care and having a totally Implanted Venous Access Device (IVAD)&#xD;
             procedure under local anesthesia for chemotherapy.&#xD;
&#xD;
          3. Absence of anxiolytic premedication.&#xD;
&#xD;
          4. Patient affiliated to social insurance.&#xD;
&#xD;
          5. Absence of contra-indication to the use of virtual reality, music therapy instrument&#xD;
             or local lidocaine anesthesia.&#xD;
&#xD;
          6. Signed informed consent form.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Patient already participated to this study.&#xD;
&#xD;
          2. Patient deprived of liberty or under legal representative or under curatorship.&#xD;
&#xD;
          3. Psychiatric disease enabling communication.&#xD;
&#xD;
          4. Deafness or visual impairement.&#xD;
&#xD;
          5. Patient under beta-blockers medication.&#xD;
&#xD;
          6. Chronic pain present and not equilibrated before the measured procedure as &gt; 3 by the&#xD;
             NRS.&#xD;
&#xD;
          7. Tracheotomy.&#xD;
&#xD;
          8. Low cervical tumor, or bilateral low cervical adenopathies.&#xD;
&#xD;
          9. Compression or jugular stenosis (uni or bilateral).&#xD;
&#xD;
         10. Jugular or subclavian thrombosis.&#xD;
&#xD;
         11. Patient under anticoagulants medication or having hesmostasis troubles.&#xD;
&#xD;
         12. Claustrophobia or thalassophobia inducing the possibility of rejecting the virtual&#xD;
             reality mask or music therapy mask.&#xD;
&#xD;
         13. Patients not speaking french.&#xD;
&#xD;
         14. Pregnant and breastfeeding women.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Pierre Fumoleau, Pr.</last_name>
    <role>Study Director</role>
    <affiliation>Institut Curie</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Abdelmalek GHIMOUZ, Dr.</last_name>
    <phone>0156245765</phone>
    <email>abdelmalek.ghimouz@curie.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Cyrine EZZILI, PhD</last_name>
    <phone>0156245765</phone>
    <email>drci.promotion@curie.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Institut Curie</name>
      <address>
        <city>Paris</city>
        <zip>75005</zip>
        <country>France</country>
      </address>
    </facility>
    <contact>
      <last_name>Abdelmalek GHIMOUZ, MD</last_name>
      <email>abdelmalek.ghimouz@curie.fr</email>
    </contact>
    <investigator>
      <last_name>Abdelmalek GHIMOUZ, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Institut Curie</name>
      <address>
        <city>Saint-cloud</city>
        <zip>92210</zip>
        <country>France</country>
      </address>
    </facility>
    <contact>
      <last_name>Aline ALBI-FELDZER, MD</last_name>
      <email>aline.albi-feldzer@curie.fr</email>
    </contact>
    <investigator>
      <last_name>Aline ALBI-FELDZER, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Gustave Roussy</name>
      <address>
        <city>Villejuif</city>
        <zip>94805</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>June 2021</verification_date>
  <study_first_submitted>March 16, 2021</study_first_submitted>
  <study_first_submitted_qc>March 16, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">March 18, 2021</study_first_posted>
  <last_update_submitted>June 29, 2021</last_update_submitted>
  <last_update_submitted_qc>June 29, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">July 1, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anesthetics</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

